Scotiabank analyst George Farmer downgraded Inmune Bio to a Sell on July 2 and set a price target of $0.60. The company’s shares closed last Thursday at $2.53. Take advantage of TipRanks Premium at 50 ...

Cheniere Energy, Inc. (NYSE:LNG) is one of the 12 Best American Energy Stocks to Buy Right Now. On July 15, Scotiabank ...

Scotiabank raised the firm’s price target on N-able (NABL) to $8.75 from $8.30 and keeps a Sector Perform rating on the shares. The company posted ...

"Spot is consolidating in a 1.16/1.17 range for the moment. Yesterday’s price action set a 'doji' candle on the daily chart ...

In addition to Scotiabank, Biogen also received a Buy from H.C. Wainwright’s Andrew Fein in a report issued today. However, on the same day, Truist Financial maintained a Hold rating on Biogen (NASDAQ ...

The Canadian Dollar (CAD) is a marginal outperformer on the day among the major currencies (along with the MXN) by dint of ...

Explore Scotiabank's digital transformation with insights on its tech strategies, innovation programs, and technology initiatives. Discover details on partnerships, product launches, and ICT budgets.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Scotiabank and KeyBank parent company KeyCorp both got something they needed out of the former's $2.8 billion investment in the latter, which closed late last year.

Canadian Imperial Bank of Commerce has inched past Bank of Nova Scotia in market capitalization to become Canada’s ...